Skip NavigationSkip to Content

Effects of Cd40 Stimulation in the Prevention of Human Ebv-Lymphomagenesis

  1. Author:
    Funakoshi, S.
    Taub, D. D.
    Asai, O.
    Hirano, A.
    Ruscetti, F. W.
    Longo, D. L.
    Murphy, W. J.
  2. Author Address

    Murphy WJ NCI FREDERICK CANC RES & DEV CTR SAIC BIOL CARCINOGENESIS & DEV PROGRAM BLDG 567 ROOM 141 FREDERICK, MD 21702 USA NCI FREDERICK CANC RES & DEV CTR SAIC BIOL CARCINOGENESIS & DEV PROGRAM FREDERICK, MD 21702 USA
    1. Year: 1997
  1. Journal: Leukemia & Lymphoma
    1. 24
    2. 3-4
    3. Pages: 187 ff.
  2. Type of Article: Review
  1. Abstract:

    CD40 is a molecule present on B lineage cells, both normal and neoplastic. Signalling through CD40 has been demonstrated to promote B cell growth and differentiation in vitro. In contrast to its effects on normal B cells, we have found that CD40 stimulation can inhibit the growth of various aggressive histology human B cell lymphomas both in vitro and in vivo. Moreover, using a human/mouse chimera model in which human EBV-induced B cell lymphomas can spontaneously arise, we have found that CD40 stimulation can prevent the occurrence of this human lymphoma in mice. However, normal human B cell engraftment and function was not adversely affected in these mice by CD40 stimulation. This indicates that CD40 stimulation is selective in its effects on aggressive histology B cell lymphomas. Thus, CD40 stimulation either by antibody or a recombinant soluble ligand, may be of potential clinical use, not only in the treatment of EBV-induced B cell lymphomas, but also in their prevention. [References: 32]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel